Codonde novoE-Selectin/AAV2

Francesca A Voza1, Barry J Byrne2, Yulexi Y Ortiz1

  • 1DeWitt Daughtry Family Department of Surgery, University of Miami School of Medicine, Miami, FL.

Annals of surgery
|July 8, 2024
PubMed
概括

这项研究确定了E-Selectin/AAV2基因治疗治疗慢性四肢缺血症的最佳剂量. 每只动物的2 × 10 ^ 11载体基因组剂量显示,四肢 perfusion 和功能显著改善,没有毒性.